Glutaminase
Glutaminase inhibitors are compounds that inhibit glutaminase, an enzyme that catalyzes the conversion of glutamine to glutamate, a critical step in cellular metabolism, especially in cancer cells. Glutaminase plays a key role in providing energy and biosynthetic precursors for rapidly proliferating cells. Inhibitors of glutaminase are important for exploring metabolic dependencies in cancer cells and developing potential therapeutic strategies. At CymitQuimica, we provide glutaminase inhibitors to support your research in cancer metabolism, cellular bioenergetics, and therapeutic discovery.
Read more
GLS1 Inhibitor-7
GLS1 Inhibitor-7 (compound 4d) serves as a GLS1 antagonist with an IC50 value of 46.7 …
Formula:
C20H17F3N4O3S2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
482.5
Ref: TM-T79340
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
BJJF078
CAS:2531244-56-9
BJJF078, an aminopiperidine, inhibits human/mouse TG2 (IC50: 41/54 nM) and TG1 (IC50: 0.16 μM), may …
Formula:
C27H29N3O6S
Purity:
98.19%
Color and Shape:
Soild
Molecular weight:
523.6
Ref: TM-T67865
| 1mg | 52.00 € | ||
| 5mg | 105.00 € | ||
| 10mg | 149.00 € | ||
| 25mg | 247.00 € | ||
| 50mg | 368.00 € | ||
| 100mg | 543.00 € | ||
| 200mg | 774.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Glutaminase C-IN-2
Glutaminase C-IN-2 (compound 11), an allosteric inhibitor of glutaminase C (GAC), exhibits potent inhibitory activity …
Formula:
C24H23N7O2S
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
473.55
Ref: TM-T78892
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
6-Diazo-5-oxo-L-nor-Leucine
CAS:157-03-9
6-Diazo-5-oxo-L-nor-Leucine (L-6-Diazo-5-oxonorleucine) is an antagonist of glutaminases (Ki : 6 μM).
Formula:
C6H9N3O3
Purity:
98.04% - 98.93%
Color and Shape:
Solid
Molecular weight:
171.15
Ref: TM-T8373
| 1mg | 47.00 € | ||
| 5mg | 119.00 € | ||
| 10mg | 171.00 € | ||
| 25mg | 277.00 € | ||
| 50mg | 425.00 € | ||
| 100mg | 620.00 € | ||
| 1mL*10mM (DMSO) | 88.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Glutaminase-IN-3
CAS:1439399-45-7
Glutaminase-IN-3 is a potent Glutaminase 1 inhibitor with potential antitumor activity and inhibits GLS1 for …
Formula:
C19H19F3N6O2S
Purity:
98.51%
Color and Shape:
Liquid
Molecular weight:
452.45
Ref: TM-T37385
| 5mg | 62.00 € | ||
| 10mg | 88.00 € | ||
| 25mg | 124.00 € | ||
| 50mg | 177.00 € | ||
| 100mg | 261.00 € | ||
| 1mL*10mM (DMSO) | 213.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
L-Albizziin
CAS:1483-07-4
L-Albizziin (L-beta-Ureidoalanine) is a glutamase inhibitor and is a glutaminyl-tRNA synthetase inhibitor.
Formula:
C4H9N3O3
Purity:
99.98%
Color and Shape:
White Powder
Molecular weight:
147.13
Ref: TM-T20121
| 5mg | 46.00 € | ||
| 10mg | 64.00 € | ||
| 25mg | 119.00 € | ||
| 50mg | 167.00 € | ||
| 100mg | 256.00 € | ||
| 200mg | 372.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Telaglenastat
CAS:1439399-58-2
Telaglenastat (CB 839) (IC50 of 24 nM), an effective, specific, and oral inhibitor, which is …
Formula:
C26H24F3N7O3S
Purity:
100% - 99.89%
Color and Shape:
Solid
Molecular weight:
571.57
Ref: TM-T6797
| 1g | 1,105.00 € | ||
| 2mg | 38.00 € | ||
| 5mg | 51.00 € | ||
| 10mg | 78.00 € | ||
| 25mg | 123.00 € | ||
| 50mg | 207.00 € | ||
| 100mg | 343.00 € | ||
| 500mg | 807.00 € | ||
| 1mL*10mM (DMSO) | 64.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
GK921
CAS:1025015-40-0
GK921 is a transglutaminase 2 (TGase) inhibitor.
Formula:
C21H20N4O
Purity:
97.44% - 99.49%
Color and Shape:
Solid
Molecular weight:
344.41
Ref: TM-T3968
| 2mg | 91.00 € | ||
| 5mg | 122.00 € | ||
| 10mg | 193.00 € | ||
| 25mg | 309.00 € | ||
| 50mg | 495.00 € | ||
| 100mg | 676.00 € | ||
| 1mL*10mM (DMSO) | 134.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
BPTES
CAS:314045-39-1
BPTES(IC50 of 0.16 μM) is an effective and specific GlutamiN/Ase GLS1 (KGA) inhibitor.
Formula:
C24H24N6O2S3
Purity:
95.83% - 99.64%
Color and Shape:
Solid
Molecular weight:
524.68
Ref: TM-T6791
| 1mg | 36.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 68.00 € | ||
| 10mg | 87.00 € | ||
| 25mg | 148.00 € | ||
| 50mg | 214.00 € | ||
| 100mg | 318.00 € | ||
| 200mg | 462.00 € | ||
| 500mg | 755.00 € | ||
| 1mL*10mM (DMSO) | 88.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Glutaminase C-IN-1
CAS:311795-38-7
Glutaminase C-IN-1 (Compound 968) is a Glutaminase C allosteric inhibitor.
Formula:
C27H27BrN2O
Purity:
99.68% - 99.82%
Color and Shape:
Solid
Molecular weight:
475.42
Ref: TM-T3964
| 2mg | 42.00 € | ||
| 5mg | 60.00 € | ||
| 10mg | 96.00 € | ||
| 25mg | 160.00 € | ||
| 50mg | 268.00 € | ||
| 100mg | 377.00 € | ||
| 500mg | 885.00 € | ||
| 1mL*10mM (DMSO) | 68.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Sirpiglenastat
CAS:2079939-05-0
Sirpiglenastat (DRP-104) is a glutamine antagonist, a prodrug of DON, with antitumor activity that acts …
Formula:
C22H27N5O5
Purity:
98.01%
Color and Shape:
Liquid
Molecular weight:
441.48
Ref: TM-T62560
| 1mg | 295.00 € | ||
| 5mg | 887.00 € | ||
| 10mg | 1,531.00 € | ||
| 25mg | 2,313.00 € | ||
| 50mg | 3,122.00 € | ||
| 100mg | 4,213.00 € |
Estimated delivery in United States, on Monday 24 Feb 2025
GLS1 Inhibitor-4
CAS:2768599-97-7
GLS1 Inhibitor-4 (41e) has 11.86 nM IC50, strong binding, disrupts glutamine metabolism, induces apoptosis, and …
Formula:
C29H27F3N10O2S2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
668.72
Ref: TM-T72679
| 25mg | 1,410.00 € | ||
| 50mg | 1,851.00 € | ||
| 100mg | 2,337.00 € |
Estimated delivery in United States, on Monday 24 Feb 2025
TG2-IN-3h
CAS:1592640-75-9
TG2-IN-3h is a highly selective, potent, cell-permeable fluorescent irreversible tissue transglutaminase (tg2) inhibitor
Formula:
C21H26N4O4S
Purity:
99.34% - 99.76%
Color and Shape:
Liquid
Molecular weight:
430.52
Ref: TM-T70413
| 25mg | 1,386.00 € | ||
| 50mg | 1,805.00 € | ||
| 100mg | 2,279.00 € |
Estimated delivery in United States, on Monday 24 Feb 2025
